These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 15491756

  • 1. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer.
    Downs LS, Judson PL, Argenta PA, Carson LF, Boente MP.
    Gynecol Oncol; 2004 Nov; 95(2):347-51. PubMed ID: 15491756
    [Abstract] [Full Text] [Related]

  • 2. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 3. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
    Palackdharry CS.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):78-83. PubMed ID: 8677455
    [Abstract] [Full Text] [Related]

  • 4. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM, Lynch TJ, Elias AD, Jacobs C, Kwiatkowski DJ, Shulman LN, Carey RW, Grossbard ML, Jauss S, Sugarbaker DJ.
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [Abstract] [Full Text] [Related]

  • 5. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.
    Tinker AV, Bhagat K, Swenerton KD, Hoskins PJ.
    Gynecol Oncol; 2005 Jul; 98(1):54-8. PubMed ID: 15904950
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G, Fei F, Mangioni C.
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [Abstract] [Full Text] [Related]

  • 8. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY, Boros L, Garrow GC, Asbury RF, Hui L.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [Abstract] [Full Text] [Related]

  • 9. Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: results of a Phase I study.
    Prince HM, Rischin D, Quinn M, Allen D, Planner R, Neesham D, Gates P, Davison J.
    Gynecol Oncol; 2001 May; 81(2):216-24. PubMed ID: 11330952
    [Abstract] [Full Text] [Related]

  • 10. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
    Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S.
    Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601
    [Abstract] [Full Text] [Related]

  • 11. Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: preliminary results of a phase I study.
    Lhommé C, Kerbrat P, Lejeune C, Guastalla JP, Fumoleau P, Goupil A, Héron JF, Cassin MA, Pruvot I, Soares JA, Chazard M.
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):48-54. PubMed ID: 8941410
    [Abstract] [Full Text] [Related]

  • 12. Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer.
    Gordon AN, Hancock KC, Matthews CM, Messing M, Stringer CA, Doherty MG, Teneriello M.
    Gynecol Oncol; 2002 Apr; 85(1):129-35. PubMed ID: 11925132
    [Abstract] [Full Text] [Related]

  • 13. Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours.
    Kosmas C, Tsavaris NB, Polyzos A, Malamos NA, Katsikas M, Antonopoulos MJ.
    Br J Cancer; 2000 Jan; 82(2):300-7. PubMed ID: 10646881
    [Abstract] [Full Text] [Related]

  • 14. A phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma.
    Dunphy FR, Boyd JH, Kim HJ, Dunphy CH, Harrison BR, Dunleavy TL, Rodriguez JJ, McDonough EM, Minster JR, Hilton JG.
    Cancer; 1997 May 15; 79(10):2016-23. PubMed ID: 9149030
    [Abstract] [Full Text] [Related]

  • 15. Treatment with paclitaxel plus carboplatin, alone or with irradiation, of advanced or recurrent endometrial carcinoma.
    Arimoto T, Nakagawa S, Yasugi T, Yoshikawa H, Kawana K, Yano T, Taketani Y.
    Gynecol Oncol; 2007 Jan 15; 104(1):32-5. PubMed ID: 16996113
    [Abstract] [Full Text] [Related]

  • 16. Concurrent radiotherapy, paclitaxel and dose escalating carboplatin in the treatment of cervical cancer--a phase I study.
    Addeo D, Blank S, Muggia F, Formenti S.
    Anticancer Res; 2008 Jan 15; 28(5B):3143-6. PubMed ID: 19031972
    [Abstract] [Full Text] [Related]

  • 17. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
    Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EE.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):515-22. PubMed ID: 17255273
    [Abstract] [Full Text] [Related]

  • 18. Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trial.
    Downs LS, Chura JC, Argenta PA, Judson PL, Ghebre R, Geller MA, Carson LF.
    Gynecol Oncol; 2011 Feb 15; 120(2):265-9. PubMed ID: 21145100
    [Abstract] [Full Text] [Related]

  • 19. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
    Palackdharry CS.
    Semin Oncol; 1997 Feb 15; 24(1 Suppl 2):S2-108-S2-112. PubMed ID: 9045327
    [Abstract] [Full Text] [Related]

  • 20. Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: a california cancer consortium phase I and molecular correlative study.
    Lara PN, Frankel P, Mack PC, Gumerlock PH, Galvin I, Martel CL, Longmate J, Doroshow JH, Lenz HJ, Lau DH, Gandara DR.
    Clin Cancer Res; 2003 Oct 01; 9(12):4356-62. PubMed ID: 14555506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.